BioDelivery Sciences International (FRA:BD5) YoY EBITDA Growth : -13.51% (As of Dec. 2021)

View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BioDelivery Sciences International's YoY EBITDA Growth for the quarter that ended in Dec. 2021 was -13.51%.

BioDelivery Sciences International's EBITDA per Share for the three months ended in Dec. 2021 was €0.10.

BioDelivery Sciences International YoY EBITDA Growth Historical Data

The historical data trend for BioDelivery Sciences International's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International YoY EBITDA Growth Chart

BioDelivery Sciences International Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

YoY EBITDA Growth

Get a 7-Day Free Trial

105.44

-511.67

155.06

133.09

20.50

BioDelivery Sciences International Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
YoY EBITDA Growth	Get a 7-Day Free Trial															164.29	10.61	152.38	-14.02	-13.51

BioDelivery Sciences International YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BioDelivery Sciences International's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

	YoY EBITDA Growth (A: Dec. 2021 )
=	(EBITDA per Share (A: Dec. 2021 )	-	EBITDA per Share (A: Dec. 2020 ))	/	\| EBITDA per Share (A: Dec. 2020 ) \|
=	(0.382	-	0.317)	/	\| 0.317 \|
=	20.50 %

BioDelivery Sciences International's YoY EBITDA Growth for the quarter that ended in Dec. 2021 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2021 )
=	(EBITDA per Share (Q: Dec. 2021 )	-	EBITDA per Share (Q: Dec. 2020 ))	/	\| EBITDA per Share (Q: Dec. 2020 )) \|
=	(0.096	-	0.111)	/	\| 0.111 \|
=	-13.51 %

BioDelivery Sciences International YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

BioDelivery Sciences International (FRA:BD5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612

Website

http://www.bdsi.com

BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines